Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [¹¹C]WAY 100635

By Frankle W.   Lombardo Ilise   Kegeles Lawrence   Slifstein Mark   Martin John   Huang Yiyun   Hwang Dah-Ren   Reich Elisa   Cangiano Claudine   Gil Roberto   Laruelle Marc   Abi-Dargham Anissa  

Psychopharmacology, Vol. 189, Iss. 2, 2006-12 ,pp. : 155-164

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms

By Güzey Cüneyt   Scordo Maria   Spina Edoardo   Landsem Veslemøy   Spigset Olav  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 233-241

Springer Publishing Company

Access to resources Recommend Favorite

Ritanserin antagonism of -chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms

By Abi-Saab Walid   Seibyl John   D'Souza Cyril   Karper Laurence   Gueorgueva Ralitza   Abi-Dargham Anissa   Wong Ma-Li   Rajhans Sachin   Erdos Joseph   Heninger George   Charney Dennis   Krystal John  

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 55-62

Springer Publishing Company

Access to resources Recommend Favorite

Physiological Indirect Effect Modeling of the Antilipolytic Effects of Adenosine A₁-Receptor Agonists

By van Schaick Erno A.   de Greef Henrik J. M. M.   Ijzerman Adriaan P.   Danhof Meindert  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 673-694

Springer Publishing Company

Access to resources Recommend Favorite

Serotonin 2A receptor antagonists for treatment of schizophrenia

By Ebdrup Bjøørn H   Rasmussen Hans   Arnt Jøørn   Glenthøøj Birte  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1211-1223

Informa Healthcare

Access to resources Recommend Favorite